Kanz L - Search Results

1

Cooperating, congenital neutropenia-associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCs.

Ritter M, Klimiankou M, Klimenkova O, Schambach A, Hoffmann D, Schmidt A, Kanz L, Link DC, Welte K, Skokowa J. Ritter M, et al. Among authors: kanz l. Ann Hematol. 2020 Oct;99(10):2329-2338. doi: 10.1007/s00277-020-04194-0. Epub 2020 Aug 3. Ann Hematol. 2020. PMID: 32821971 Free PMC article.

2

Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34⁺ cells preceding leukemic transformation.

Dannenmann B, Zahabi A, Mir P, Oswald B, Bernhard R, Klimiankou M, Morishima T, Schulze-Osthoff K, Zeidler C, Kanz L, Lachmann N, Moritz T, Welte K, Skokowa J. Dannenmann B, et al. Among authors: kanz l. Exp Hematol. 2019 Mar;71:51-60. doi: 10.1016/j.exphem.2018.12.006. Epub 2019 Jan 4. Exp Hematol. 2019. PMID: 30615903 Free article.

3

GM-CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling.

Koch C, Samareh B, Morishima T, Mir P, Kanz L, Zeidler C, Skokowa J, Welte K. Koch C, et al. Among authors: kanz l. Ann Hematol. 2017 Mar;96(3):345-353. doi: 10.1007/s00277-016-2894-5. Epub 2016 Dec 14. Ann Hematol. 2017. PMID: 27966038

4

Corrigendum to 'Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation' <[Experimental Hematology, Volume 71, 2019;71:51-60]>

Dannenmann B, Zahabi A, Mir P, Oswald B, Bernhard R, Klimiankou M, Morishima T, Schulze-Osthoff K, Zeidler C, Kanz L, Lachmann N, Moritz T, Welte K, Skokowa J. Dannenmann B, et al. Among authors: kanz l. Exp Hematol. 2022 Oct;114:61. doi: 10.1016/j.exphem.2022.07.302. Epub 2022 Aug 8. Exp Hematol. 2022. PMID: 35952718 Free article. No abstract available.

5

Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies.

Schneidawind D, Federmann B, Buechele C, Helwig A, Schmohl J, Vogel W, Faul C, Kanz L, Bethge WA. Schneidawind D, et al. Among authors: kanz l. Ann Hematol. 2016 Jan;95(1):115-124. doi: 10.1007/s00277-015-2512-y. Epub 2015 Sep 28. Ann Hematol. 2016. PMID: 26411736

6

Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia.

Schneidawind D, Federmann B, Faul C, Vogel W, Kanz L, Bethge WA. Schneidawind D, et al. Among authors: kanz l. Ann Hematol. 2013 Oct;92(10):1389-95. doi: 10.1007/s00277-013-1774-5. Epub 2013 May 8. Ann Hematol. 2013. PMID: 23652585

7

Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experience.

Roerden M, Sökler M, Kanz L, Bethge W, Vogel W, Walz JS. Roerden M, et al. Among authors: kanz l. Ann Hematol. 2020 Feb;99(2):265-276. doi: 10.1007/s00277-019-03900-x. Epub 2020 Jan 2. Ann Hematol. 2020. PMID: 31897675

8

Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.

Schneidawind C, Hagmaier V, Faul C, Kanz L, Bethge W, Schneidawind D. Schneidawind C, et al. Among authors: kanz l. Ann Hematol. 2018 Dec;97(12):2491-2500. doi: 10.1007/s00277-018-3454-y. Epub 2018 Jul 31. Ann Hematol. 2018. PMID: 30066039 Clinical Trial.

9

Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells.

Weisel KC, Yildirim S, Schweikle E, Kanz L, Möhle R. Weisel KC, et al. Among authors: kanz l. Ann Hematol. 2009 Mar;88(3):203-11. doi: 10.1007/s00277-008-0605-6. Epub 2008 Sep 17. Ann Hematol. 2009. PMID: 18797870

10

The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.

Both A, Krauter J, Damm F, Thol F, Göhring G, Heuser M, Ottmann O, Lübbert M, Wattad M, Kanz L, Schlimok G, Raghavachar A, Fiedler W, Kirchner H, Brugger W, Schlegelberger B, Heil G, Ganser A, Wagner K. Both A, et al. Among authors: kanz l. Ann Hematol. 2017 Jun;96(6):895-904. doi: 10.1007/s00277-017-2967-0. Epub 2017 Mar 22. Ann Hematol. 2017. PMID: 28331964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters